Rep. Stephanie I. Bice

Maddy summaryHR 2555, the Freedom of Association in Higher Education Act of 2025, protects students who join or form single-sex social organizations (like fraternities or sororities) at colleges. It prohibits colleges receiving federal funds from taking negative actions against these students or organizations solely because they limit membership to one sex - such as denying housing, financial aid, leadership roles, or recognition. The bill ensures students can join such groups without coercion and stops colleges from imposing unfair recruitment rules on single-sex organizations compared to others. It does not require colleges to recognize single-sex groups, allow organizations to set their own membership rules, or override Title IX protections.

Maddy summaryThis House resolution formally honors the life and legacy of the late Representative Kay Granger from Texas, recognizing her historic achievements in public service. The bill highlights her roles as the first woman elected mayor of Fort Worth, the first Republican woman to represent Texas in the U.S. House, and the first Republican woman to chair the House Committee on Appropriations. It also acknowledges her contributions to national defense, including her work on the F-35 fighter jet program and the naming of a Navy ship for Fort Worth. The resolution expresses sympathy to Granger's family and directs the Clerk of the House to send an official copy of the document to her loved ones.

Maddy summaryHR 7008, the Stop Insider Trading Act, restricts Members of Congress, their spouses, and dependent children from purchasing certain investments like stocks in publicly traded companies. It requires 7-14 days' advance public notice before selling any such investment, including the sale date, description, and number of shares. Exceptions apply for work-related transactions (e.g., employer compensation) and reinvesting dividends. Violations trigger a fee of $2,000 or 10% of the investment’s value (whichever is greater), plus any net gain, paid from personal funds - not congressional allowances or campaign donations. The bill aims to prevent conflicts of interest by increasing transparency around congressional financial dealings.

Maddy summaryThis resolution expresses support for designating the first week of August as National Community Health Center Week to honor the contributions of these facilities. It encourages all Americans to visit their local health centers during this time to celebrate the partnership between these organizations and the communities they serve. The bill highlights how community health centers provide affordable, comprehensive care to millions of people, particularly in rural and underserved areas, while integrating services like dental care, behavioral health, and pharmacy support. By recognizing these centers, the resolution aims to raise awareness of their role in improving public health outcomes and supporting local economies.

Maddy summaryThis bill expands the State Department's Regional Technology Officer program to specifically include experts in biotechnology and emerging life sciences. It mandates that these officers receive specialized training in areas such as gene editing, biosecurity, and international biotechnology regulations to better support U.S. foreign policy goals. The legislation requires the Secretary of State to hire biotechnology-focused officers by fiscal year 2026 and submit a detailed implementation plan to Congress within 180 days. Additionally, the bill creates an exemption from hiring freezes to allow the Department to recruit the necessary personnel and establishes a requirement for annual reports on the program's progress and diplomatic outcomes.

Maddy summaryThis bill reauthorizes and expands the Accelerating Access to Critical Therapies for ALS Act through 2031, extending funding for research into treatments for amyotrophic lateral sclerosis. It requires drug manufacturers to share interim clinical trial data with the FDA to better assess the progress of investigational drugs and clarifies that phase 3 clinical trial definitions include combined phase 2/3 trials and planned trials not yet enrolling participants. The legislation also mandates the FDA to publish an updated five-year action plan for ALS and other rare neurodegenerative diseases, including resource needs and coordination strategies with broader disease communities. Additionally, the bill requires the Government Accountability Office to submit a report on the program's implementation four years after enactment.

Maddy summaryThe STRATA Act of 2026 establishes a new program within the Department of State to foster international partnerships focused on advancing critical minerals technologies, aiming to strengthen U.S. supply chains and national security. This initiative allows the Secretary of State to form alliances with allied and partner nations, universities, and private companies while explicitly prohibiting collaborations with designated countries of concern such as China and Russia. Key provisions include the creation of International Centers of Excellence for research and training, the development of a digital platform to connect stakeholders with funding opportunities, and the establishment of clear guidelines for intellectual property and data security within these partnerships. The program authorizes the use of specific funding sources to support joint projects in extraction, recycling, and manufacturing, with a requirement that all activities conclude within ten years of the bill's enactment.

Maddy summaryHR 6213, the Heat Workforce Standards Act of 2025, prohibits the U.S. Department of Labor from finalizing, implementing, or enforcing OSHA's proposed "Heat Injury and Illness Prevention" standard (published August 30, 2024). This bill directly blocks the specific regulatory proposal targeting heat safety in both outdoor and indoor work settings. It does not create new requirements or affect workers; it solely prevents the implementation of the existing OSHA proposal. The bill is procedural, focusing on halting a regulatory action rather than establishing new policy.

Maddy summaryHR 7184, the PRESS Act, targets equipment used to manufacture illegal drugs by making it unlawful to sell specific items like tableting machines, gelatin capsules, or related chemicals when the seller knows the equipment will be used to produce controlled substances for unlawful U.S. importation. It directly affects manufacturers and distributors of these drug-making tools who have knowledge or reasonable cause to believe their products will facilitate illegal drug trafficking. The bill adds new prohibitions to the Controlled Substances Act and increases potential prison sentences for violations, with penalties reaching up to 20 years for major offenses involving large quantities of equipment or chemicals. These changes aim to disrupt the supply chain for illicit synthetic drugs by holding equipment sellers accountable for their intended use.

Maddy summaryThis bill requires Medicare Advantage plans to implement electronic pre-approval systems for medical services by 2028 and meet transparency reporting standards starting in 2027. Plans must publicly report data on approval/denial rates, appeal outcomes, response times, and technology use for pre-approval requests, including details on how denials relate to clinical criteria. It establishes a 24-hour response timeframe for certain requests and mandates annual reviews of pre-approval requirements based on data and input from seniors and providers. The law directly affects Medicare Advantage plans, seniors enrolled in these plans, and healthcare providers who submit pre-approval requests. These changes aim to make the pre-approval process faster, more transparent, and more accountable for seniors seeking covered medical services.